Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03928275
Recruitment Status : Not yet recruiting
First Posted : April 26, 2019
Last Update Posted : April 13, 2020
Sponsor:
Collaborator:
Nova Scotia Health Authority
Information provided by (Responsible Party):
Carman Giacomantonio, Nova Scotia Health Authority

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : September 1, 2025
Estimated Study Completion Date : September 1, 2030